Illinois Municipal Retirement Fund Has $9.05 Million Position in Agilent Technologies, Inc. (NYSE:A)

Illinois Municipal Retirement Fund reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 13.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 69,793 shares of the medical research company’s stock after selling 11,170 shares during the period. Illinois Municipal Retirement Fund’s holdings in Agilent Technologies were worth $9,047,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Crewe Advisors LLC boosted its position in Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 101 shares during the last quarter. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies during the 4th quarter valued at about $26,000. VisionPoint Advisory Group LLC acquired a new stake in Agilent Technologies during the fourth quarter worth approximately $29,000. Ridgewood Investments LLC bought a new stake in Agilent Technologies in the second quarter worth approximately $29,000. Finally, Rise Advisors LLC lifted its stake in Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after buying an additional 190 shares during the period. 87.42% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. Citigroup increased their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Robert W. Baird cut their price target on Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a report on Thursday, May 30th. JPMorgan Chase & Co. reduced their price objective on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Wolfe Research cut Agilent Technologies from an “outperform” rating to a “peer perform” rating in a report on Thursday, June 27th. Finally, Evercore ISI boosted their price target on shares of Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a research note on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $141.60.

Agilent Technologies Stock Performance

Shares of A opened at $137.20 on Friday. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The stock’s fifty day moving average price is $135.62 and its two-hundred day moving average price is $139.06. The firm has a market cap of $40.03 billion, a PE ratio of 32.43, a PEG ratio of 6.63 and a beta of 1.05.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The company had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the company posted $1.43 EPS. Agilent Technologies’s revenue was down 5.6% compared to the same quarter last year. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the firm’s stock in a transaction on Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the transaction, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares in the company, valued at approximately $6,595,494.08. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 18,916 shares of company stock valued at $2,557,230. 0.33% of the stock is currently owned by corporate insiders.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.